{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:27:59Z","timestamp":1793845679546,"version":"4.6.1"},"reference-count":140,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,3]],"date-time":"2027-08-03T00:00:00Z","timestamp":1817251200000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK121204-A1"],"award-info":[{"award-number":["R01DK121204-A1"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R42DK120261"],"award-info":[{"award-number":["R42DK120261"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mayocp.2026.04.020","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:58:01Z","timestamp":1778108281000},"page":"1400-1415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut Oxalate Transport and Gut Microbiome as Potential Therapeutic Targets for Hyperoxaluria and Hyperoxalemia: Implications for Related Human Disease"],"prefix":"10.1016","volume":"101","author":[{"given":"Khalid A.","family":"Abdelhalim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asadoor Amirkhani","family":"Namagerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Alfuraiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4744-8665","authenticated-orcid":false,"given":"Hatim A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1523-1755.2001.00488.x","article-title":"Contribution of dietary oxalate to urinary oxalate excretion","volume":"59","author":"Holmes","year":"2001","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00240-004-0437-3","article-title":"The impact of dietary oxalate on kidney stone formation","volume":"32","author":"Holmes","year":"2004","journal-title":"Urol Res"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/01.ju.0000169476.85935.e2","article-title":"Dietary oxalate loads and renal oxalate handling","volume":"174","author":"Holmes","year":"2005","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.mayocp.2026.04.020_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1681\/ASN.0000000000000176","article-title":"Endogenous oxalate synthesis and urinary oxalate excretion","volume":"34","author":"Fargue","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.mayocp.2026.04.020_bib5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ki.2011.287","article-title":"Hyperoxaluria: a gut-kidney axis?","volume":"80","author":"Robijn","year":"2011","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNH.0000000000000229","article-title":"Oxalate, inflammasome, and progression of kidney disease","volume":"25","author":"Ermer","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5527\/wjn.v4.i2.235","article-title":"Primary and secondary hyperoxaluria: understanding the enigma","volume":"4","author":"Bhasin","year":"2015","journal-title":"World J Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib8","first-page":"440","article-title":"Renal elimination kinetics and plasma half-life of oxalate in man","volume":"34","author":"Osswald","year":"1979","journal-title":"Urol Int"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/cs0630047","article-title":"Renal clearance of [14C]oxalate: comparison of constant-infusion with single-injection techniques","volume":"63","author":"Prenen","year":"1982","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","article-title":"Prevalence of kidney stones in the United States","volume":"62","author":"Scales","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.mayocp.2026.04.020_bib11","series-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","article-title":"Emergency department visits and hospital admissions for kidney stone disease, 2009","author":"Foster","year":"2012"},{"key":"10.1016\/j.mayocp.2026.04.020_bib12","first-page":"486","article-title":"Economic impact of urologic disease. Urologic Diseases in America. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service","author":"Litwin","year":"2012","journal-title":"US Department of Health and Human Services"},{"issue":"14","key":"10.1016\/j.mayocp.2026.04.020_bib13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.1977.03280150089036","article-title":"The natural history of calcium urolithiasis","volume":"238","author":"Coe","year":"1977","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mayocp.2026.04.020_bib14","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1172\/JCI26662","article-title":"Kidney stone disease","volume":"115","author":"Coe","year":"2005","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib15","first-page":"220","article-title":"Incidence of upper urinary tract stones","volume":"13","author":"Ljunghall","year":"1987","journal-title":"Miner Electrolyte Metab"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib16","first-page":"11","article-title":"Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease","volume":"35","author":"Baggio","year":"1983","journal-title":"Nephron"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1464-410X.1991.tb15383.x","article-title":"Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors","volume":"68","author":"Laminski","year":"1991","journal-title":"Br J Urol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0002-9343(99)80080-1","article-title":"Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol","volume":"98","author":"Levy","year":"1995","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002708","article-title":"24-h uric acid excretion and the risk of kidney stones","volume":"73","author":"Curhan","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib20","first-page":"391","article-title":"Importance of mild hyperoxaluria in the pathogenesis of urolithiasis\u2014new evidence from studies in the Arabian peninsula","volume":"7","author":"Robertson","year":"1993","journal-title":"Scanning Microsc"},{"issue":"12","key":"10.1016\/j.mayocp.2026.04.020_bib21","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/ndt\/gfaa281","article-title":"Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria","volume":"36","author":"D'Costa","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mayocp.2026.04.020_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5287","article-title":"Kidney stones and kidney function loss: a cohort study","volume":"345","author":"Alexander","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamainternmed.2018.7980","article-title":"Association of urinary oxalate excretion with the risk of chronic kidney disease progression","volume":"179","author":"Waikar","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/ndt\/gfn697","article-title":"Oxalate deposits in biopsies from native and transplanted kidneys, and impact on graft function","volume":"24","author":"Bagnasco","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/ndt\/gfy271","article-title":"The association of calcium oxalate deposition in kidney allografts with graft and patient survival","volume":"35","author":"Palsson","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MNH.0000000000000515","article-title":"Urinary oxalate as a potential mediator of kidney disease in diabetes mellitus and obesity","volume":"28","author":"Efe","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"10.1016\/j.mayocp.2026.04.020_bib27","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000381219","article-title":"The relationship between serum oxalic acid, central hemodynamic parameters and colonization by Oxalobacter formigenes in hemodialysis patients","volume":"5","author":"Gulhan","year":"2015","journal-title":"Cardiorenal Med"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1046\/j.1523-1755.1998.00066.x","article-title":"Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria","volume":"54","author":"Hoppe","year":"1998","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.mayocp.2026.04.020_bib30","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1681\/ASN.2020121793","article-title":"High oxalate concentrations correlate with increased risk for sudden cardiac death in dialysis patients","volume":"32","author":"Pfau","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.mayocp.2026.04.020_bib31","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.00488.2015","article-title":"Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL\/6 mice","volume":"310","author":"Mulay","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00240-004-0445-3","article-title":"Intestinal transport of an obdurate anion: oxalate","volume":"33","author":"Hatch","year":"2005","journal-title":"Urol Res"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0022-5347(17)36400-5","article-title":"The stomach: a new and powerful oxalate absorption site in man","volume":"149","author":"Hautmann","year":"1993","journal-title":"J Urol"},{"issue":"11","key":"10.1016\/j.mayocp.2026.04.020_bib34","first-page":"1749","article-title":"Clinical investigation on gastric oxalate absorption","volume":"116","author":"Chen","year":"2003","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MNH.0000000000000690","article-title":"Gut-kidney axis in oxalate homeostasis","volume":"30","author":"Alshaikh","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"12","key":"10.1016\/j.mayocp.2026.04.020_bib36","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1681\/ASN.2011040433","article-title":"Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion","volume":"22","author":"Knauf","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib37","first-page":"1109","article-title":"Dietary oxalate and its intestinal absorption","volume":"9","author":"Holmes","year":"1995","journal-title":"Scanning Microsc"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00240-006-0048-2","article-title":"Chitosan does not reduce post-prandial urinary oxalate excretion","volume":"34","author":"Wolf","year":"2006","journal-title":"Urol Res"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ndt\/gfv005","article-title":"Enteric hyperoxaluria: an important cause of end-stage kidney disease","volume":"31","author":"Nazzal","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.08000520","article-title":"Pathophysiology and treatment of enteric hyperoxaluria","volume":"16","author":"Witting","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib41","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.2014.352","article-title":"Kidney stones are common after bariatric surgery","volume":"87","author":"Lieske","year":"2015","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib42","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1572-0241.1998.156_b.x","article-title":"Renal and urologic complications of inflammatory bowel disease","volume":"93","author":"Pardi","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib43","first-page":"371","article-title":"Renal stone formation in patients with inflammatory bowel disease","volume":"7","author":"Caudarella","year":"1993","journal-title":"Scanning Microsc"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1523-1755.2004.00790.x","article-title":"Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion","volume":"66","author":"Ferraz","year":"2004","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.mayocp.2026.04.020_bib45","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00467-012-2126-8","article-title":"Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease","volume":"27","author":"Hueppelshaeuser","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01774220","article-title":"Urinary factors of kidney stone formation in patients with Crohn's disease","volume":"66","author":"Bohles","year":"1988","journal-title":"Klin Wochenschr"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib47","first-page":"238","article-title":"Clinical and urinary characteristics of urolithiasis in ulcerative colitis","volume":"77","author":"Fukushima","year":"1982","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000233282","article-title":"Mechanisms and functional implications of intestinal barrier defects","volume":"27","author":"Shen","year":"2009","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib49","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00266.2018","article-title":"Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria","volume":"316","author":"Bashir","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM197702102960602","article-title":"Importance of the colon in enteric hyperoxaluria","volume":"296","author":"Dobbins","year":"1977","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/00365527809181767","article-title":"Enteric hyperoxaluria: dependence on small intestinal resection, colectomy, and steatorrhoea in chronic inflammatory bowel disease","volume":"13","author":"Hylander","year":"1978","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00365527809181746","article-title":"Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria","volume":"13","author":"Modigliani","year":"1978","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ng1762","article-title":"Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6","volume":"38","author":"Jiang","year":"2006","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib54","doi-asserted-by":"crossref","first-page":"G719","DOI":"10.1152\/ajpgi.00481.2005","article-title":"Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice","volume":"290","author":"Freel","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib55","doi-asserted-by":"crossref","first-page":"G573","DOI":"10.1152\/ajpgi.00338.2001","article-title":"Identification of an apical Cl\u2212\/HCO3\u2212 exchanger in the small intestine","volume":"282","author":"Wang","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue\u2013specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2016020132","article-title":"Oxalobacter formigenes\u2013derived bioactive factors stimulate oxalate transport by intestinal epithelial cells","volume":"28","author":"Arvans","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib58","doi-asserted-by":"crossref","first-page":"C372","DOI":"10.1152\/ajpcell.00135.2019","article-title":"Activation of the PKA signaling pathway stimulates oxalate transport by human intestinal Caco2-BBE cells","volume":"318","author":"Arvans","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib59","doi-asserted-by":"crossref","first-page":"C46","DOI":"10.1152\/ajpcell.00075.2011","article-title":"Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells","volume":"302","author":"Hassan","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib60","doi-asserted-by":"crossref","first-page":"G918","DOI":"10.1152\/ajpgi.00251.2009","article-title":"Parsing apical oxalate exchange in Caco-2BBe1 monolayers: siRNA knockdown of SLC26A6 reveals the role and properties of PAT-1","volume":"297","author":"Freel","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib61","doi-asserted-by":"crossref","first-page":"C344","DOI":"10.1152\/ajpcell.00466.2021","article-title":"Sel1-like proteins and peptides are the major Oxalobacter formigenes\u2013derived factors stimulating oxalate transport by human intestinal epithelial cells","volume":"325","author":"Arvans","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10.1016\/j.mayocp.2026.04.020_bib62","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1074\/jbc.R114.635995","article-title":"Human enteroids\/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology","volume":"291","author":"Zachos","year":"2016","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13287-024-03768-3","article-title":"Current applications of intestinal organoids: a review","volume":"15","author":"Xiang","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib64","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/gutjnl-2013-306651","article-title":"Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays","volume":"64","author":"VanDussen","year":"2015","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib65","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/mi.2013.98","article-title":"Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis","volume":"7","author":"Moon","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib66","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI31474","article-title":"Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice","volume":"120","author":"Dawson","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib67","doi-asserted-by":"crossref","first-page":"C52","DOI":"10.1152\/ajpcell.00385.2011","article-title":"Sat1 is dispensable for active oxalate secretion in mouse duodenum","volume":"303","author":"Ko","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib68","doi-asserted-by":"crossref","first-page":"G82","DOI":"10.1152\/ajpgi.00299.2018","article-title":"Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia","volume":"316","author":"Whittamore","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib69","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00424-008-0611-5","article-title":"The liver and kidney expression of sulfate anion transporter sat-1 in rats exhibits male-dominant gender differences","volume":"457","author":"Brzica","year":"2009","journal-title":"Pflugers Arch"},{"issue":"8","key":"10.1016\/j.mayocp.2026.04.020_bib70","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/002215540104900805","article-title":"SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types","volume":"49","author":"Haila","year":"2001","journal-title":"J Histochem Cytochem"},{"issue":"20","key":"10.1016\/j.mayocp.2026.04.020_bib71","doi-asserted-by":"crossref","first-page":"12307","DOI":"10.1074\/jbc.273.20.12307","article-title":"Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans","volume":"273","author":"Satoh","year":"1998","journal-title":"J Biol Chem"},{"issue":"2-3","key":"10.1016\/j.mayocp.2026.04.020_bib72","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.mam.2012.07.009","article-title":"The SLC26 gene family of anion transporters and channels","volume":"34","author":"Alper","year":"2013","journal-title":"Mol Aspects Med"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib73","doi-asserted-by":"crossref","first-page":"C1363","DOI":"10.1152\/ajpcell.00004.2010","article-title":"Regulated transport of sulfate and oxalate by SLC26A2\/DTDST","volume":"298","author":"Heneghan","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/hmg\/ddi079","article-title":"A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype","volume":"14","author":"Forlino","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.mayocp.2026.04.020_bib75","doi-asserted-by":"crossref","first-page":"G520","DOI":"10.1152\/ajpgi.00167.2013","article-title":"Transcellular oxalate and Cl\u2212 absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate","volume":"305","author":"Freel","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"pt 1","key":"10.1016\/j.mayocp.2026.04.020_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1113\/jphysiol.2003.039818","article-title":"Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes","volume":"549","author":"Chernova","year":"2003","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib77","doi-asserted-by":"crossref","first-page":"C1485","DOI":"10.1152\/ajpcell.00447.2006","article-title":"Regulation of anion exchanger Slc26a6 by protein kinase C","volume":"292","author":"Hassan","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib78","doi-asserted-by":"crossref","first-page":"C78","DOI":"10.1152\/ajpcell.00339.2012","article-title":"Extracellular nucleotides inhibit oxalate transport by human intestinal Caco-2-BBe cells through PKC-delta activation","volume":"305","author":"Amin","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib79","doi-asserted-by":"crossref","first-page":"C687","DOI":"10.1152\/ajpcell.00024.2017","article-title":"Adenosinergic signaling inhibits oxalate transport by human intestinal Caco2-BBE cells through the A2B adenosine receptor","volume":"315","author":"Jung","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib80","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.kint.2017.11.011","article-title":"Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria","volume":"93","author":"Amin","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib81","doi-asserted-by":"crossref","first-page":"C866","DOI":"10.1152\/ajpcell.00171.2016","article-title":"N-Glycosylation critically regulates function of oxalate transporter SLC26A6","volume":"311","author":"Thomson","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3-4","key":"10.1016\/j.mayocp.2026.04.020_bib82","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00374396","article-title":"Characteristics of the transport of oxalate and other ions across rabbit proximal colon","volume":"423","author":"Hatch","year":"1993","journal-title":"Pflugers Arch"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib83","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.ki.5000162","article-title":"Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion","volume":"69","author":"Hatch","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib84","doi-asserted-by":"crossref","first-page":"G461","DOI":"10.1152\/ajpgi.00434.2010","article-title":"Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter","volume":"300","author":"Hatch","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2026.04.020_bib85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00374677","article-title":"Mechanisms of oxalate absorption and secretion across the rabbit distal colon","volume":"426","author":"Hatch","year":"1994","journal-title":"Pflugers Arch"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib86","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1681\/ASN.V561339","article-title":"Intestinal excretion of oxalate in chronic renal failure","volume":"5","author":"Hatch","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.mayocp.2026.04.020_bib87","first-page":"S324","article-title":"Regulatory aspects of oxalate secretion in enteric oxalate elimination","author":"Hatch","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib88","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00240-003-0367-5","article-title":"Angiotensin II involvement in adaptive enteric oxalate excretion in rats with chronic renal failure induced by hyperoxaluria","volume":"31","author":"Hatch","year":"2003","journal-title":"Urol Res"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib89","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1681\/ASN.V351098","article-title":"Extrarenal clearance of oxalate increases with progression of renal failure in the rat","volume":"3","author":"Costello","year":"1992","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000066300","article-title":"Renal and intestinal handling of oxalate following oxalate loading in rats","volume":"23","author":"Hatch","year":"2003","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1016\/j.mayocp.2026.04.020_bib91","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1681\/ASN.2020010105","article-title":"Enteric oxalate secretion mediated by Slc26a6 defends against hyperoxalemia in murine models of chronic kidney disease","volume":"31","author":"Neumeier","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib92","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00240-015-0801-5","article-title":"Chronic metabolic acidosis reduces urinary oxalate excretion and promotes intestinal oxalate secretion in the rat","volume":"43","author":"Whittamore","year":"2015","journal-title":"Urolithiasis"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib93","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00240-018-1067-5","article-title":"Oxalate transport by the mouse intestine in vitro is not affected by chronic challenges to systemic acid-base homeostasis","volume":"47","author":"Whittamore","year":"2019","journal-title":"Urolithiasis"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib94","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12282","article-title":"Effects of acid-base variables and the role of carbonic anhydrase on oxalate secretion by the mouse intestine in vitro","volume":"3","author":"Whittamore","year":"2015","journal-title":"Physiol Rep"},{"issue":"13","key":"10.1016\/j.mayocp.2026.04.020_bib95","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153359","article-title":"Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis","volume":"7","author":"Cil","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib96","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib98","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.mayocp.2026.04.020_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114400","article-title":"Microbiome as an immune regulator in health, disease, and therapeutics","volume":"188","author":"Juarez","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib100","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1038\/s41467-019-12476-z","article-title":"Interplay between the human gut microbiome and host metabolism","volume":"10","author":"Visconti","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib102","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.chom.2017.06.014","article-title":"Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity","volume":"22","author":"Xiao","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib103","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40168-018-0472-x","article-title":"Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum","volume":"6","author":"Crusell","year":"2018","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib104","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12020-018-1813-z","article-title":"Microbiome and its relation to gestational diabetes","volume":"64","author":"Cortez","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.mayocp.2026.04.020_bib105","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7253978","article-title":"Alterations of gut microbiota in type 2 diabetes individuals and the confounding effect of antidiabetic agents","volume":"2020","author":"Almugadam","year":"2020","journal-title":"J Diabetes Res"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib106","first-page":"315","article-title":"Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: why and how","volume":"22","author":"Hou","year":"2022","journal-title":"Bosn J Basic Med Sci"},{"issue":"10","key":"10.1016\/j.mayocp.2026.04.020_bib107","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/nu11102291","article-title":"Impact of fecal microbiota transplantation on obesity and metabolic syndrome\u2014a systematic review","volume":"11","author":"Zhang","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.mayocp.2026.04.020_bib108","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1017\/S0007114520000380","article-title":"Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism","volume":"123","author":"Amabebe","year":"2020","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib109","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2217\/fmb.14.140","article-title":"Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?","volume":"10","author":"Barros","year":"2015","journal-title":"Future Microbiol"},{"issue":"7","key":"10.1016\/j.mayocp.2026.04.020_bib110","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease","volume":"14","author":"Yang","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.678","article-title":"Altered gut microbiota and microbial biomarkers associated with chronic kidney disease","volume":"8","author":"Lun","year":"2019","journal-title":"Microbiologyopen"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib112","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/nu12030605","article-title":"The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases","volume":"12","author":"Sanchez-Rodriguez","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.mayocp.2026.04.020_bib113","article-title":"Gut microbiota: a novel regulator of cardiovascular disease and key factor in the therapeutic effects of flavonoids","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.mayocp.2026.04.020_bib114","article-title":"Periodontitis exacerbates and promotes the progression of chronic kidney disease through oral flora, cytokines, and oxidative stress","volume":"12","author":"Li","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib115","first-page":"105","article-title":"The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?","volume":"26","author":"Robertson","year":"1980","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib116","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/healthcare11030424","article-title":"Epidemiology of kidney stones","volume":"11","author":"Stamatelou","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib117","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MNH.0000000000000518","article-title":"Enteric hyperoxaluria: role of microbiota and antibiotics","volume":"28","author":"Liu","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib118","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1681\/ASN.2007101058","article-title":"Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones","volume":"19","author":"Kaufman","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"9133","key":"10.1016\/j.mayocp.2026.04.020_bib119","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(98)03038-4","article-title":"Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria","volume":"352","author":"Sidhu","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mayocp.2026.04.020_bib120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/089277903321618743","article-title":"Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate","volume":"17","author":"Troxel","year":"2003","journal-title":"J Endourol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib121","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0302-2838(03)00318-X","article-title":"Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis","volume":"44","author":"Kwak","year":"2003","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib122","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1442-2042.2003.00634.x","article-title":"Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation","volume":"10","author":"Mikami","year":"2003","journal-title":"Int J Urol"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2011.04.008","article-title":"Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers","volume":"78","author":"Knight","year":"2011","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.mayocp.2026.04.020_bib124","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/ki.2013.104","article-title":"The role of Oxalobacter formigenes colonization in calcium oxalate stone disease","volume":"83","author":"Siener","year":"2013","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00240-013-0601-8","article-title":"A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion","volume":"41","author":"Hatch","year":"2013","journal-title":"Urolithiasis"},{"issue":"11","key":"10.1016\/j.mayocp.2026.04.020_bib126","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1093\/ndt\/gfr107","article-title":"Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria","volume":"26","author":"Hoppe","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib127","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00467-016-3553-8","article-title":"A randomised phase I\/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria","volume":"32","author":"Hoppe","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00240-017-0998-6","article-title":"A randomised phase II\/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria","volume":"46","author":"Milliner","year":"2018","journal-title":"Urolithiasis"},{"issue":"7","key":"10.1016\/j.mayocp.2026.04.020_bib130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.ki.5001707","article-title":"Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1","volume":"70","author":"Hoppe","year":"2006","journal-title":"Kidney Int"},{"issue":"18","key":"10.1016\/j.mayocp.2026.04.020_bib131","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00544-21","article-title":"Forty Years of Oxalobacter formigenes, a gutsy oxalate-degrading specialist","volume":"87","author":"Daniel","year":"2021","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.mayocp.2026.04.020_bib132","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1091581809353611","article-title":"14-day repeat-dose oral toxicity evaluation of oxazyme in rats and dogs","volume":"29","author":"Cowley","year":"2010","journal-title":"Int J Toxicol"},{"issue":"2","key":"10.1016\/j.mayocp.2026.04.020_bib133","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000151395","article-title":"Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria","volume":"29","author":"Grujic","year":"2009","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.mayocp.2026.04.020_bib134","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100053","article-title":"Randomized placebo-controlled trial of reloxaliase in enteric hyperoxaluria","volume":"1","author":"Lieske","year":"2022","journal-title":"NEJM Evid"},{"issue":"4","key":"10.1016\/j.mayocp.2026.04.020_bib135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11255-019-02098-1","article-title":"ALLN-177, oral enzyme therapy for hyperoxaluria","volume":"51","author":"Lingeman","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.mayocp.2026.04.020_bib136","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00248-016-0800-2","article-title":"Microbial community transplant results in increased and long-term oxalate degradation","volume":"72","author":"Miller","year":"2016","journal-title":"Microb Ecol"},{"issue":"23","key":"10.1016\/j.mayocp.2026.04.020_bib137","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1128\/AEM.02381-16","article-title":"Response of germ-free mice to colonization with O. formigenes and altered Schaedler flora","volume":"82","author":"Li","year":"2016","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"10.1016\/j.mayocp.2026.04.020_bib138","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00088-17","article-title":"The induction of oxalate metabolism in vivo is more effective with functional microbial communities than with functional microbial species","volume":"2","author":"Miller","year":"2017","journal-title":"mSystems"},{"issue":"13","key":"10.1016\/j.mayocp.2026.04.020_bib139","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnv092","article-title":"Methanogen communities in stools of humans of different age and health status and co-occurrence with bacteria","volume":"362","author":"Vanderhaeghen","year":"2015","journal-title":"FEMS Microbiol Lett"},{"issue":"9","key":"10.1016\/j.mayocp.2026.04.020_bib140","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1128\/aem.59.9.3062-3069.1993","article-title":"Oxalate- and glyoxylate-dependent growth and acetogenesis by Clostridium thermoaceticum","volume":"59","author":"Daniel","year":"1993","journal-title":"Appl Environ Microbiol"},{"issue":"12","key":"10.1016\/j.mayocp.2026.04.020_bib141","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.bbapap.2008.08.012","article-title":"Acetogenesis and the Wood-Ljungdahl pathway of CO2 fixation","volume":"1784","author":"Ragsdale","year":"2008","journal-title":"Biochim Biophys Acta"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619626184973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619626184973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:00:40Z","timestamp":1793844040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619626184973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":140,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0025619626184973"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2026.04.020","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut Oxalate Transport and Gut Microbiome as Potential Therapeutic Targets for Hyperoxaluria and Hyperoxalemia: Implications for Related Human Disease","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2026.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}